$5.00
-0.20-3.85%
Pre-Market: Dec 13, 9:03 AM EDT
Comments
Loading...
Oculis Holding (OCSAW) Forecast
NewsEarningsOculis Holding (OCSAW) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOculis Holding (NASDAQ:OCSAW) Stock Quotes, Forecast and News Summary
Oculis Holding Stock (NASDAQ: OCSAW) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Oculis Holding (OCSAW) stock?
You can purchase shares of Oculis Holding (NASDAQ:OCSAW) through any online brokerage.
Who are Oculis Holding (OCSAW) competitors?
Other companies in Oculis Holding’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).
What is the forecast, or price target, for Oculis Holding (OCSAW) stock?
There is no analysis for Oculis Holding to provide a consensus price target.
What is the current price for Oculis Holding (OCSAW)?
The stock price for Oculis Holding (NASDAQ: OCSAW) is $5 last updated December 13, 2024 at 9:03 AM EST.
Does Oculis Holding (OCSAW) pay a dividend?
There are no upcoming dividends for Oculis Holding.
When is Oculis Holding (NASDAQ:OCSAW) reporting earnings?
Oculis Holding does not have any upcoming earnings scheduled.
Is Oculis Holding (OCSAW) going to split?
There is no upcoming split for Oculis Holding.
What sector and industry does Oculis Holding (OCSAW) operate in?
Oculis Holding is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.